Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
Authors
Keywords
Colorectal cancer, Guideline, Surgery, Chemotherapy, Endoscopy, Radiotherapy
Journal
International Journal of Clinical Oncology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-16
DOI
10.1007/s10147-019-01485-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic Impact of R0 Resection and Targeted Therapy for Colorectal Cancer with Synchronous Peritoneal Metastasis
- (2018) Dai Shida et al. ANNALS OF SURGICAL ONCOLOGY
- Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, Third Edition
- (2018) Kentaro Yamazaki et al. CANCER SCIENCE
- A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study
- (2018) Eiji Oki et al. Clinical Colorectal Cancer
- Validation study for development of the Japan NBI Expert Team classification of colorectal lesions
- (2018) Mineo Iwatate et al. Digestive Endoscopy
- Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG0212)
- (2018) Masaaki Ito et al. EJSO
- A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur–uracil versus surgery alone in stage II colon cancer: SACURA trial
- (2018) Chu Matsuda et al. EUROPEAN JOURNAL OF CANCER
- Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA Study
- (2018) Jianming Xu et al. JOURNAL OF CLINICAL ONCOLOGY
- Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial
- (2018) Rui-Hua Xu et al. LANCET ONCOLOGY
- Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
- (2018) Axel Grothey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAF V600E -Mutant Colorectal Cancer
- (2018) Ryan B. Corcoran et al. Cancer Discovery
- Long-term outcomes after resection of para-aortic lymph node metastasis from left-sided colon and rectal cancer
- (2017) Nozomu Nakai et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Long-term outcomes after treatment for T1 colorectal carcinoma: a multicenter retrospective cohort study of Hiroshima GI Endoscopy Research Group
- (2017) Yuzuru Tamaru et al. JOURNAL OF GASTROENTEROLOGY
- Carbon-ion radiotherapy for isolated para-aortic lymph node recurrence from colorectal cancer
- (2017) Yuka Isozaki et al. JOURNAL OF SURGICAL ONCOLOGY
- Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
- (2017) Michael J Overman et al. LANCET ONCOLOGY
- Potential impact of lateral lymph node dissection (LLND) for low rectal cancer on prognoses and local control: A comparison of 2 high-volume centers in Japan that employ different policies concerning LLND
- (2017) Yukihide Kanemitsu et al. SURGERY
- A systematic review to assess the management of patients with cerebral metastases secondary to colorectal cancer
- (2017) I. L. Silva et al. Techniques in Coloproctology
- A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic BRAF -Mutant Colorectal Cancer
- (2017) Robin M.J.M. van Geel et al. Cancer Discovery
- Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)
- (2016) K. Yamazaki et al. ANNALS OF ONCOLOGY
- A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC)
- (2016) E. Oki et al. ANNALS OF ONCOLOGY
- Survival and Prognostic Factors for Metachronous Peritoneal Metastasis in Patients with Colon Cancer
- (2016) Hiroshi Nagata et al. ANNALS OF SURGICAL ONCOLOGY
- Randomized study of FOLFIRI plus either panitumumab or bevacizumab for wild-type KRAS colorectal cancer-WJOG 6210G
- (2016) Kohei Shitara et al. CANCER SCIENCE
- Uracil-Tegafur and Oral Leucovorin Combined With Bevacizumab in Elderly Patients (Aged ≥ 75 Years) With Metastatic Colorectal Cancer: A Multicenter, Phase II Trial (Joint Study of Bevacizumab, Oral Leucovorin, and Uracil-Tegafur in Elderly Patients [J-BLUE] Study)
- (2016) Tomohiro Nishina et al. Clinical Colorectal Cancer
- Male sexual dysfunction after rectal cancer surgery: Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212
- (2016) S. Saito et al. EJSO
- Surveillance after curative treatment for colorectal cancer
- (2016) Eric P. van der Stok et al. Nature Reviews Clinical Oncology
- Management of para-aortic lymph node metastasis in colorectal patients: A systemic review
- (2016) J.S.M. Wong et al. SURGICAL ONCOLOGY-OXFORD
- Impact of Lateral Pelvic Lymph Node Dissection on the Survival of Patients with T3 and T4 Low Rectal Cancer
- (2016) Heita Ozawa et al. WORLD JOURNAL OF SURGERY
- Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial
- (2016) Kiyoshi Hasegawa et al. PLoS One
- Randomized phase III trial of treatment duration for oral uracil and tegafur plus leucovorin as adjuvant chemotherapy for patients with stage IIB/III colon cancer: final results of JFMC33-0502
- (2015) S. Sadahiro et al. ANNALS OF ONCOLOGY
- FOLFIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer after first-line bevacizumab plus oxaliplatin-based therapy: the randomized phase III EAGLE study†
- (2015) S. Iwamoto et al. ANNALS OF ONCOLOGY
- Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer
- (2015) Takashi Akiyoshi et al. ANNALS OF SURGICAL ONCOLOGY
- Oncologic Outcomes of Colon Cancer Patients with Extraregional Lymph Node Metastasis: Comparison of Isolated Paraaortic Lymph Node Metastasis with Resectable Liver Metastasis
- (2015) Sung Uk Bae et al. ANNALS OF SURGICAL ONCOLOGY
- A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer
- (2015) Akihito Kawazoe et al. BMC CANCER
- Surgical management of patients with colorectal cancer and simultaneous liver and lung metastases
- (2015) A. Andres et al. BRITISH JOURNAL OF SURGERY
- Japanese Society of Medical Oncology Clinical Guidelines:RAS(KRAS/NRAS) mutation testing in colorectal cancer patients
- (2015) Hiroya Taniguchi et al. CANCER SCIENCE
- Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus
- (2015) René Adam et al. CANCER TREATMENT REVIEWS
- JGES guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resection
- (2015) Shinji Tanaka et al. Digestive Endoscopy
- Clinical Significance of Para-Aortic Lymph Node Dissection for Advanced or Metastatic Colorectal Cancer in the Current Era of Modern Chemotherapy
- (2015) Atsuki Arimoto et al. DIGESTIVE SURGERY
- Practice Guideline for the Surveillance of Patients After Curative Treatment of Colon and Rectal Cancer
- (2015) Scott R. Steele et al. DISEASES OF THE COLON & RECTUM
- Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
- (2015) Pedro Pimentel-Nunes et al. ENDOSCOPY
- Combination chemotherapy with bevacizumab and S-1 for elderly patients with metastatic colorectal cancer (BASIC trial)
- (2015) M. Yoshida et al. EUROPEAN JOURNAL OF CANCER
- First-line single-agent panitumumab in frail elderly patients with wild-type KRAS metastatic colorectal cancer and poor prognostic factors: A phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours
- (2015) J. Sastre et al. EUROPEAN JOURNAL OF CANCER
- Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial
- (2015) Carmen J. Allegra et al. JNCI-Journal of the National Cancer Institute
- FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
- (2015) Chiara Cremolini et al. LANCET ONCOLOGY
- Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study
- (2015) Josep Tabernero et al. LANCET ONCOLOGY
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer
- (2015) Robert J. Mayer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single-Agent Panitumumab in Frail Elderly Patients With Advanced RAS and BRAF Wild-Type Colorectal Cancer: Challenging Drug Label to Light Up New Hope
- (2015) F. Pietrantonio et al. ONCOLOGIST
- Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial
- (2015) Carmen J. Allegra et al. JNCI-Journal of the National Cancer Institute
- S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial)
- (2014) M. Yoshida et al. ANNALS OF ONCOLOGY
- Neoadjuvant Chemoradiotherapy Affects the Indications for Lateral Pelvic Node Dissection in Mid/Low Rectal Cancer with Clinically Suspected Lateral Node Involvement: A Multicenter Retrospective Cohort Study
- (2014) Heung-Kwon Oh et al. ANNALS OF SURGICAL ONCOLOGY
- Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: Final results of JCOG0205
- (2014) Yasuhiro Shimada et al. EUROPEAN JOURNAL OF CANCER
- Factors associated with technical difficulties and adverse events of colorectal endoscopic submucosal dissection: retrospective exploratory factor analysis of a multicenter prospective cohort
- (2014) Yoji Takeuchi et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Impact of D3 lymph node dissection on survival for patients with T3 and T4 colon cancer
- (2014) Kenjiro Kotake et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Effect of PET Before Liver Resection on Surgical Management for Colorectal Adenocarcinoma Metastases
- (2014) Carol-Anne Moulton et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
- (2014) Fotios Loupakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predictive factors for complications in endoscopic resection of large colorectal lesions: a multicenter prospective study
- (2014) Yoshiki Wada et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) R. Labianca et al. ANNALS OF ONCOLOGY
- Intentionally curative treatment of locally recurrent rectal cancer: a systematic review
- (2013) Pieter Tanis et al. CANADIAN JOURNAL OF SURGERY
- FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer
- (2013) F. Loupakis et al. EUROPEAN JOURNAL OF CANCER
- GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength
- (2013) Jeffrey C. Andrews et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations
- (2013) Jeff Andrews et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Follow-Up Care, Surveillance Protocol, and Secondary Prevention Measures for Survivors of Colorectal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement
- (2013) Jeffrey A. Meyerhardt et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical benefit of surgery for stage IV colorectal cancer with synchronous peritoneal metastasis
- (2013) Hirotoshi Kobayashi et al. JOURNAL OF GASTROENTEROLOGY
- Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial
- (2013) Yasuhide Yamada et al. LANCET ONCOLOGY
- Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
- (2013) Bernard Nordlinger et al. LANCET ONCOLOGY
- Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial
- (2013) Matthew T Seymour et al. LANCET ONCOLOGY
- Prognostic factors for peritoneal carcinomatosis originating from colorectal cancer: an analysis of 921 patients from a multi-institutional database
- (2013) Heita Ozawa et al. SURGERY TODAY
- Current status of endoscopic resection strategy for large, early colorectal neoplasia in Japan
- (2013) Takeshi Nakajima et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- Repeat liver resection for recurrent colorectal metastases: a single‐centre, 13‐year experience
- (2013) Narendra Battula et al. HPB
- Results of a Japanese Nationwide Multi-Institutional Study on Lateral Pelvic Lymph Node Metastasis in Low Rectal Cancer
- (2012) Takashi Akiyoshi et al. ANNALS OF SURGERY
- Prognostic Factors After Pulmonary Metastasectomy for Colorectal Cancer and Rationale for Determining Surgical Indications
- (2012) Tomohiko Iida et al. ANNALS OF SURGERY
- Risk Factors for Survival after Lung Metastasectomy in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis
- (2012) Michel Gonzalez et al. ANNALS OF SURGICAL ONCOLOGY
- Systematic review of outcomes after intersphincteric resection for low rectal cancer
- (2012) S. T. Martin et al. BRITISH JOURNAL OF SURGERY
- Long-term Outcomes After Resection for Submucosal Invasive Colorectal Cancers
- (2012) Hiroaki Ikematsu et al. GASTROENTEROLOGY
- Outcomes of surgery without HIPEC for synchronous peritoneal metastasis from colorectal cancer: data from a multi-center registry
- (2012) Hirotoshi Kobayashi et al. International Journal of Clinical Oncology
- GRADE guidelines: 13. Preparing Summary of Findings tables and evidence profiles—continuous outcomes
- (2012) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes
- (2012) Gordon Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence
- (2012) Massimo Brunetti et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 12. Preparing Summary of Findings tables—binary outcomes
- (2012) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
- (2012) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04
- (2012) Samuel Y. Ngan et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer
- (2012) Jean-Pierre Gérard et al. JOURNAL OF CLINICAL ONCOLOGY
- Brain metastasis from colorectal cancer: Prognostic factors and survival
- (2012) Shingo Noura et al. JOURNAL OF SURGICAL ONCOLOGY
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) Axel Grothey et al. LANCET
- TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial
- (2012) Takayuki Yoshino et al. LANCET ONCOLOGY
- Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial
- (2012) Shin Fujita et al. LANCET ONCOLOGY
- Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial
- (2012) Ralf-Dieter Hofheinz et al. LANCET ONCOLOGY
- Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial
- (2012) Claus Rödel et al. LANCET ONCOLOGY
- Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
- (2012) Jaafar Bennouna et al. LANCET ONCOLOGY
- Stereotactic body radiotherapy for oligometastases
- (2012) Alison C Tree et al. LANCET ONCOLOGY
- Prognostic factors in patients undergoing complete resection of pulmonary metastases of colorectal cancer: a multi-institutional cumulative follow-up study
- (2012) Tomoichiro Hirosawa et al. SURGERY TODAY
- Outcome of surgical resection for recurrent pulmonary metastasis from colorectal carcinoma
- (2011) Ryu Kanzaki et al. AMERICAN JOURNAL OF SURGERY
- A Systematic Review of Clinical Response and Survival Outcomes of Downsizing Systemic Chemotherapy and Rescue Liver Surgery in Patients with Initially Unresectable Colorectal Liver Metastases
- (2011) Vincent W. T. Lam et al. ANNALS OF SURGICAL ONCOLOGY
- BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
- (2011) T Yokota et al. BRITISH JOURNAL OF CANCER
- Gastrointestinal cancer and brain metastasis
- (2011) Pauline H. Go et al. CANCER
- Risk of lymph node metastasis in patients with pedunculated type early invasive colorectal cancer: A retrospective multicenter study
- (2011) Takahisa Matsuda et al. CANCER SCIENCE
- Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1*28 and/or UGT1A1*6 polymorphisms
- (2011) Taroh Satoh et al. CANCER SCIENCE
- MID-TERM PROGNOSIS AFTER ENDOSCOPIC RESECTION FOR SUBMUCOSAL COLORECTAL CARCINOMA: SUMMARY OF A MULTICENTER QUESTIONNAIRE SURVEY CONDUCTED BY THE COLORECTAL ENDOSCOPIC RESECTION STANDARDIZATION IMPLEMENTATION WORKING GROUP IN JAPANESE SOCIETY FOR CANCER O
- (2011) Shiro Oka et al. Digestive Endoscopy
- Long-Term Results of Intersphincteric Resection for Low Rectal Cancer
- (2011) Kazutaka Yamada et al. DISEASES OF THE COLON & RECTUM
- Intramural and Mesorectal Distal Spread Detected by Whole-Mount Sections in the Determination of Optimal Distal Resection Margin in Patients Undergoing Surgery for Rectosigmoid or Rectal Cancer Without Preoperative Therapy
- (2011) Yoshifumi Shimada et al. DISEASES OF THE COLON & RECTUM
- First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer
- (2011) Claus-Henning Köhne et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- GRADE guidelines: 9. Rating up the quality of evidence
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 7. Rating the quality of evidence—inconsistency
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 3. Rating the quality of evidence
- (2011) Howard Balshem et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 8. Rating the quality of evidence—indirectness
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 5. Rating the quality of evidence—publication bias
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
- (2011) Gordon Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines 6. Rating the quality of evidence—imprecision
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses
- (2011) Greg Yothers et al. JOURNAL OF CLINICAL ONCOLOGY
- Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer
- (2011) Daniel G. Haller et al. JOURNAL OF CLINICAL ONCOLOGY
- Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial
- (2011) Carlo Aschele et al. JOURNAL OF CLINICAL ONCOLOGY
- Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
- (2011) Paul W. Sperduto et al. JOURNAL OF CLINICAL ONCOLOGY
- Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial
- (2011) Willem van Gijn et al. LANCET ONCOLOGY
- Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy
- (2010) Rebecca C. Auer et al. CANCER
- A prospective, multicenter study of 1111 colorectal endoscopic submucosal dissections (with video)
- (2010) Yutaka Saito et al. GASTROINTESTINAL ENDOSCOPY
- GRADE guidelines: 2. Framing the question and deciding on important outcomes
- (2010) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer
- (2010) Marc Peeters et al. JOURNAL OF CLINICAL ONCOLOGY
- Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study
- (2010) Niall C. Tebbutt et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
- (2010) Jean-Yves Douillard et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2
- (2010) Jean-Pierre Gérard et al. JOURNAL OF CLINICAL ONCOLOGY
- Disappearing Colorectal Liver Metastases after Chemotherapy: Should we be Concerned?
- (2010) Mark G. van Vledder et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Brain metastases from colorectal carcinoma: prognostic factors and outcome
- (2010) Minkyu Jung et al. JOURNAL OF NEURO-ONCOLOGY
- Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study)
- (2010) Kei Muro et al. LANCET ONCOLOGY
- Diagnostic Imaging of Colorectal Liver Metastases with CT, MR Imaging, FDG PET, and/or FDG PET/CT: A Meta-Analysis of Prospective Studies Including Patients Who Have Not Previously Undergone Treatment
- (2010) Maarten Christian Niekel et al. RADIOLOGY
- Extended Lymph Node Dissection for Rectal Cancer with Radiologically Diagnosed Extramesenteric Lymph Node Metastasis
- (2009) Byung Soh Min et al. ANNALS OF SURGICAL ONCOLOGY
- Factors influencing survival after complete resection of pulmonary metastases from colorectal cancer
- (2009) K. Watanabe et al. BRITISH JOURNAL OF SURGERY
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
- (2009) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- Extensive lymphadenectomy in colorectal cancer with isolated para-aortic lymph node metastasis below the level of renal vessels
- (2009) Pyong Wha Choi et al. JOURNAL OF SURGICAL ONCOLOGY
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stereotactic body radiotherapy for isolated paraaorticlymph node recurrence from colorectal cancer
- (2009) Mi-Sook Kim et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study
- (2008) M. L. Rothenberg et al. ANNALS OF ONCOLOGY
- Neurosurgical management and postoperative whole-brain radiotherapy for colorectal cancer patients with symptomatic brain metastases
- (2008) Giuseppe Aprile et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Complete Pathologic Response After Preoperative Chemotherapy for Colorectal Liver Metastases: Myth or Reality?
- (2008) René Adam et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer
- (2008) Jim Cassidy et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
- (2008) Leonard B. Saltz et al. JOURNAL OF CLINICAL ONCOLOGY
- EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer
- (2008) Alberto F. Sobrero et al. JOURNAL OF CLINICAL ONCOLOGY
- Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
- (2008) Rafael G. Amado et al. JOURNAL OF CLINICAL ONCOLOGY
- Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
- (2008) Carsten Bokemeyer et al. JOURNAL OF CLINICAL ONCOLOGY
- Colorectal endoscopic submucosal dissection: present status and future perspective, including its differentiation from endoscopic mucosal resection
- (2008) Shinji Tanaka et al. JOURNAL OF GASTROENTEROLOGY
- Interval Period Tumor Progression: Does Delayed Hepatectomy Detect Occult Metastases in Synchronous Colorectal Liver Metastases?
- (2008) Hiroyuki Yoshidome et al. JOURNAL OF GASTROINTESTINAL SURGERY
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Going from evidence to recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
- Isolated paraaortic lymph-node recurrence after the curative resection of colorectal carcinoma
- (2007) Byung Soh Min et al. JOURNAL OF SURGICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now